MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women.

preprint OA: closed
Full text JSON View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-03 ⓘ

This cross-sectional study in 419 women found that higher BMI and oral contraceptive use were associated with increased MRI background parenchymal enhancement, while preventive medications like tamoxifen reduced it.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-03 · read from full text ⓘ

The provided text does not contain the abstract or body of a research paper titled "MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women." Instead, it displays an error message from the Research Square platform indicating that the resource was not found. Consequently, no specific study population, methods, findings, or limitations can be summarized because the actual manuscript content is missing. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Background: Histologically normal breast fibroglandular tissue (FGT) enhances on contrast MRI and is called background parenchymal enhancement (BPE). Having high BPE is associated with an increased risk of breast cancer. We examined the relationship between MRI-FGT (a volumetric assessment of breast density) and BPE and breast cancer risk factors.Methods: This was a cross-sectional study of 419 women without breast cancer undergoing contrast-enhanced breast MRI. All women completed a questionnaire at the time of MRI. Prevalence ratios (PR) and 95% confidence intervals (CI) describing the relationship between breast cancer risk factors and BPE and MRI-FGT were generated using modified Poisson regression. Results: In multivariable adjusted models a positive association between BMI and BPE was observed, with a 5-unit increase in BMI associated with a 16% and 38% increase in prevalence of high BPE in pre- and post-menopausal women respectively. Conversely, a strong inverse relationship between BMI and MRI-FGT was observed in both pre- (PR=0.65, 95% CI 0.57, 0.76 per 5-unit increase of BMI) and post-menopausal (PR=0.67, 95% CI 0.57, 0.79, per 5-unit increase in BMI) women. Current use of oral contraceptives was associated with high BPE while use of preventive medication (e.g., tamoxifen) was associated with low BPE. Conclusion: This study identifies patient characteristics and exposures associated with BPE and MRI-FGT. BPE is a new imaging marker of breast cancer risk. The results of this study provide further support for the role of hormonal exposures on BPE.
Full text 3,807 characters · extracted from preprint-html · click to expand
An error has occurred | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Help Center Sign In Submit a Preprint Something went wrong :( An error has occurred. An error has occurred. Please check back later. You can also try returning to the home page . Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About In Review Editorial Policies Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"configuration":{"journal":{"name":"Research Square","identity":"researchsquare","logo":false,"directSubmit":true,"showInReviewInBrowserTitle":false,"showJournalNav":false,"filterSubjectAreas":false,"article":{"citationFormat":"${authors} ${title}, ${postedDate}, PREPRINT (Version ${version}) available at Research Square [https://doi.org/${doi}]","showBadges":true,"showPdf":true,"showPeerReviewFeatures":true,"submitForQcEnabled":true,"versionDisclaimer":"Please note that this article has not completed peer review."},"blurb":"A new pre-publication platform making research communication faster, fairer, and more useful.","dashboard":{"submissionUrl":"/submission"},"discover":{"showArticleStatusSearch":true,"showArticleTypeSearch":true},"home":"landing","login":{"title":"Research Square","copy":"A new pre-publication platform making research communication faster, fairer, and more useful.","embeddedVideo":true},"submission":{"pages":[{"route":"abstract","field":"manuscriptAbstract","name":"Abstract","tooltip":"Please do not put keywords in the abstract box; use the keywords section instead.","required":true},{"route":"authors","field":"author","name":"Author Information","tooltip":""},{"route":"file","field":"file","name":"Manuscript File","tooltip":"","multiple":false},{"route":"figures","field":"figures","name":"Figures","tooltip":""},{"route":"supplementary","field":"supplementary","name":"Supplementary Files","tooltip":""},{"route":"subjects","field":"subjectAreas","name":"Subject Areas","tooltip":"","required":true},{"route":"keywords","field":"keywords","name":"Keywords","tooltip":"","required":true},{"route":"type","field":"articleType","name":"Article Type","tooltip":"","required":true}],"renderNav":true}}}}},"page":"/error","query":{"message":"Resource not found"},"buildId":"qQ7_6M8ijIrYJ9CiyUnPg","isFallback":false,"isExperimentalCompile":false,"gip":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: preprint-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00